L1CAM and breast carcinoma: It has been reported that brain metastatic cells from breast cancer and lung cancer induce large amounts of serine protease inhibitors (SERPINs) to prevent plasminogen activator (PA) destruction of L1CAM and mediate the spread of metastatic cells [43].